D. E. Shaw & Co., Inc.

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in MIRM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,472,633

-$59,422,603 QoQ

Shares Held

167,489

-82.3% QoQ

Ownership

0.275%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 95.19669948474228.ToString("F0")% Shared 0.ToString("F0")% None 4.803300515257718.ToString("F0")%

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. MIRM ranks #54 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,472,633	167,489	-82.3%	Shares	Defined	2026-05-15
2025-12-31	$74,895,236	948,161	+2.7%	Shares	Defined	2026-02-17
2025-09-30	$67,702,444	923,509	+66.4%	Shares	Defined	2025-11-14
2025-06-30	$28,241,761	554,957	+2.1%	Shares	Defined	2025-08-14
2025-03-31	$24,474,628	543,277	+245.3%	Shares	Defined	2025-05-15
2024-12-31	$6,506,504	157,352	+609.5%	Shares	Defined	2025-02-14
2023-12-31	$654,694	22,178	-4.9%	Shares	Defined	2024-02-14
2023-09-30	$737,038	23,324	-35.5%	Shares	Defined	2023-11-14
2022-09-30	$759,406	36,145	+45.5%	Shares	Defined	2022-11-14
2022-06-30	$483,308	24,836	+134.7%	Shares	Defined	2022-08-15
2020-06-30	$205,906	10,581	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.